Pacira BioSciences Inc (PCRX)
26.81
+0.71
(+2.72%)
USD |
NASDAQ |
Apr 23, 16:00
26.80
-0.01
(-0.04%)
After-Hours: 20:00
Pacira BioSciences Total Assets (Quarterly): 1.574B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.574B |
| September 30, 2023 | 1.534B |
| June 30, 2023 | 1.542B |
| March 31, 2023 | 1.523B |
| December 31, 2022 | 1.681B |
| September 30, 2022 | 1.734B |
| June 30, 2022 | 1.734B |
| March 31, 2022 | 1.891B |
| December 31, 2021 | 2.075B |
| September 30, 2021 | 1.356B |
| June 30, 2021 | 1.326B |
| March 31, 2021 | 1.288B |
| December 31, 2020 | 1.275B |
| September 30, 2020 | 1.220B |
| June 30, 2020 | 866.11M |
| March 31, 2020 | 821.38M |
| December 31, 2019 | 831.06M |
| September 30, 2019 | 807.49M |
| June 30, 2019 | 787.84M |
| March 31, 2019 | 719.16M |
| December 31, 2018 | 689.35M |
| September 30, 2018 | 659.04M |
| June 30, 2018 | 642.68M |
| March 31, 2018 | 622.04M |
| December 31, 2017 | 628.37M |
| Date | Value |
|---|---|
| September 30, 2017 | 606.09M |
| June 30, 2017 | 605.74M |
| March 31, 2017 | 599.96M |
| December 31, 2016 | 391.47M |
| September 30, 2016 | 381.15M |
| June 30, 2016 | 400.70M |
| March 31, 2016 | 391.21M |
| December 31, 2015 | 387.74M |
| September 30, 2015 | 368.99M |
| June 30, 2015 | 354.99M |
| March 31, 2015 | 335.03M |
| December 31, 2014 | 326.07M |
| September 30, 2014 | 305.39M |
| June 30, 2014 | 292.08M |
| March 31, 2014 | 163.69M |
| December 31, 2013 | 169.82M |
| September 30, 2013 | 172.40M |
| June 30, 2013 | 178.43M |
| March 31, 2013 | 185.24M |
| December 31, 2012 | 112.05M |
| September 30, 2012 | 132.83M |
| June 30, 2012 | 142.85M |
| March 31, 2012 | 94.26M |
| December 31, 2011 | 113.49M |
| September 30, 2011 | 77.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
787.84M
Minimum
Jun 2019
2.075B
Maximum
Dec 2021
1.362B
Average
1.356B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Dynavax Technologies Corp | 997.10M |
| Arbutus Biopharma Corp | 144.40M |
| Chimerix Inc | 212.77M |
| Karyopharm Therapeutics Inc | 240.44M |
| FibroGen Inc | 423.53M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 704.26M |
| Shareholders Equity (Quarterly) | 870.13M |
| Debt to Equity Ratio | 0.6004 |
| Current Ratio | 5.237 |
| Net Debt Paydown Yield | 2.87% |